This inventor holds 5 USPTO granted patents. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2002
Title: Daryl Reed: Innovator in Cancer Research
Introduction
Daryl Reed is a prominent inventor based in Epalinges, Switzerland. He has made significant contributions to the field of cancer research, particularly in the development of immunogenic compositions related to tumor rejection antigens.
Latest Patents
Daryl Reed holds 5 patents that focus on innovative approaches to cancer treatment. His latest patents include immunogenic compositions of tumor rejection antigen precursor MAGE-10 and an adjuvant. These patents encompass isolated cDNA molecules that encode the tumor rejection antigen precursor MAGE-10, the protein itself, antibodies to it, and various uses of these inventions. Additionally, he has developed MAGE-10 encoding cDNA, antibodies specific to the molecule, and their applications.
Career Highlights
Daryl Reed is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in cancer immunology. His work has been instrumental in understanding and developing therapies that target specific tumor antigens.
Collaborations
Daryl has collaborated with notable colleagues in his field, including Donata Rimoldi and Victor Jongeneel. Their combined expertise has contributed to the success of various research initiatives.
Conclusion
Daryl Reed's innovative work in cancer research and his contributions to the development of immunogenic compositions highlight his role as a leading inventor in the field. His patents and collaborations continue to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile